Helping Adults With COPD or Asthma Use Inhalers Correctly
Tests inhaler technique teaching in adults with COPD or asthma.
Plain-language title generated from the registry record
Registry title: Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Key facts
- Where
- Hradec Králové, CzechiaSee the site
Where in Czechia
- University Hospital Hradec KraloveHradec Králové, CzechiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Charles University, Czech Republic
- Trial code
- NCT07183657
- Record updated
- 30 September 2025
- Original description
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.Read full original descriptionShow less
Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
Inclusion: signed informed consent,; age ≥ 18 years,; previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria,; ability to cooperate,; at least 8 weeks without exacerbation,; use of a particular inhaler for at least 3 months; signed informed consent,; completed education in medicine, pharmacy, or nursing,; more than one year of working experience,; care for patients taking inhaled therapy for BA/COPD.
Exclusion: pre-terminal/terminal stage of any disease,; uncooperative patient,; significant limitation of mobility or cognitive functions; HEALTHCARE PROFESSIONALS.
PATIENTS.